People

Mission

To equitably advance precision medicine at UCSF and beyond by sharing information and fostering connections across dispersed parts of the university; identifying priorities, challenges, and opportunities; and working to advance key precision medicine programs and initiatives.

Keith Yamamoto, PhD

Vice Chancellor of Science Policy and Strategy
Professor of Cellular Molecular Pharmacology
Director, UCSF Precision Medicine
Cellular Molecular Pharmacology

As UCSF’s first vice chancellor for Science Policy and Strategy, Keith Yamamoto leads efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, by working within the University as well as influencing and shaping science policy at the state and national levels and beyond.

Mark Anderson, MD, PhD

Professor of Medicine; Michelle M. Friend Endowed Chair in Diabetes Research / Diabetes Center
Diabetes Center

EDUCATION/CLINICAL TRAINING
MD: MD, PhD, University of Chicago, 1994
Residency: University of Minnesota, MD, Internal Medicine, 1994-1997
Chief Resident, University of Minnesota 1997-1998
Fellowship: Massachusetts General Hospital, Adult Endocrinology, 1998-2001
Board Certification: Endocrinology and Metabolism, 2001, Renewed 2012

Alan Ashworth, PhD

President, UCSF Helen Diller Family Comprehensive Cancer Center
Senior Vice President for Cancer Services, UCSF Health
Program Lead: Precision Cancer Medicine
Medicine

Alan Ashworth, PhD, FRS, is President of the UCSF Helen Diller Family Comprehensive Cancer Center, and Sr. Vice President for Cancer Services with UCSF Health. Prior to joining UCSF in January 2015, he served as Chief Executive of the Institute of Cancer Research (ICR) and the Director of the Breakthrough Breast Cancer Research Centre in London, United Kingdom. 

Kirsten Bibbins-Domingo, PhD, MD, MAS

Professor and Chair of the Department of Epidemiology and Biostatistics
Vice Dean for Population Health and Health Equity, School of Medicine
Program Lead: Precision Population Health
Epidemiology & Biostatistics

Kirsten Bibbins-Domingo, PhD, MD, MAS is the Lee Goldman, MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics. She is currently the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network.

Michael Blum, MD

Associate Vice Chancellor for Informatics
Chief Digital Transformation Officer
Element Lead: Digital Health
Medicine

Dr. Michael Blum is the Associate Vice Chancellor for Informatics and the Chief Digital Transformation Officer at the University of California, San Francisco. Dr. Blum is responsible for UCSF’s strategic design and implementation of informatics and digital health capabilities in support of clinical care delivery and discovery. He is also a Professor of Medicine in Cardiology, specializing in preventative cardiology and the care of patients with congestive heart failure, valvular heart disease, and general cardiology. Dr.

Riley Bove, MD

Assistant Professor, Neurology
Neurology

Riley’s first academic passion was anthropology, which she pursued at Harvard College (Phi Beta Kappa), and through a Fulbright grant in Mali. She obtained her MD from Harvard Medical School in 2007, completed her residency in the combined Massachusetts General Hospital – Brigham and Women’s Hospital Neurology program, a clinical research fellowship at the Partners MS Center, and a Masters Degree through Harvard Medical School’s Clinical Investigator Training Program. She has received research support from the NIH and the National MS Society, among others.

Esteban G. Burchard, MD, MPH

Professor, Bioengineering
Professor, Lung Biology, School of Medicine
Bioengineering

Asthma is the most common chronic disease among children affecting Puerto Rican and African American children more than other races/ethnicities. We study the interplay between genes and the environment to determine the root causes of asthma health disparities in children and adolescents to identify and develop targeted interventions to improve asthma outcomes. The complexities of asthma and respiratory disease require a multi-disciplinary approach.

Atul Butte, MD, PhD

Director of the Bakar Computational Health Sciences Institute
Professor of Pediatrics
Element Lead:Computational Health Sciences
Pediatrics

Atul Butte, MD, PhD is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute (bchsi.ucsf.edu) at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire University of California Health System, with 20 health professional schools, 6 medical centers, and 10 hospitals. Dr.

Harold Collard, MD, MS

Vice Chancellor for Research
Professor of Medicine and Health Policy
Element Lead: Clinical Discovery
Vice Chancellor Research

Dr. Harold R. Collard is the vice chancellor for Clinical Research at UCSF and professor of Medicine and Health Policy.

Elena Flowers, PhD, RN

Associate Professor, Physiological Nursing
Physiological Nursing

My program of research focuses on precision medicine and risk for type 2 diabetes in high risk racial groups. Specifically, I am studying the utility of epigenetic biomarkers for risk detection and prediction of response to risk-reduction interventions. Current studies include investigation of microRNA expression in individuals who are insulin resistant, and prediction of response to both pharmacologic and non-pharmacologic interventions.

Kathy Giacomini, PhD, BSPharm

Dean School of Pharmacy
Professor of Bioengineering and Therapeutic Sciences
Dean's Office

The Giacomini research group focuses on expanding our understanding of membrane transporters. Membrane transporters are of great biological and pharmacological importance, as they play a major role in human physiology and in drug disposition and response. Major questions addressed in the laboratory include: What is the function of orphan membrane transporters? What is the in vivo role of membrane transporters in the disposition of endogenous solutes as well as in drug disposition and response?

Maria Glymour, ScD, MS

Professor, Epidemiology & Biostatistics
Epidemiology & Biostatistics

My research focuses on how social factors experienced across the lifecourse, from infancy to adulthood, influence cognitive function, dementia, stroke, and other health outcomes in old age. I am especially interested in education and other exposures amenable to policy interventions. Current cohorts of elderly in the US were exposed to profound social changes during the 20th century when we revolutionized access to high school.

Pages